Untitled Document  

The term ‘Halal’ is an Arabic which literally means ‘lawful’ or ‘permissible’. In Islam, this term refers to many aspects of daily life, but in relation to the production of products such as food, drink, pharmaceuticals and cosmetics, it refers to the composition of the products and the environment in which they are produced. The ingredients used must be judged to be lawful according to the principles of Islamic law.
.The most important principle relates to the slaughter of meat. Briefly, for slaughter of an animal to be considered ‘Halal’, the name of God must be invoked before the slaughter is carried outIt must be done with a sharp knife in one movement, severing the trachea, oesophagus, both jugular veins and both carotid arteries. The animal must then be allowed to bleed out completely. Throughout the process, pain to the animal must be minimised.

Benefits of HALAL Certification
Halal Certification can benefit both the consumer and the producer :

For producers:
• They can offer their products to the global Muslim market, which constitutes approximately 1.6 billion people (20% of the world’s population) and described as the most untapped market in the world;
• They can benefit from HAB’s Worldwide Standard, which has been devised by expert Islamic scholars and leaders in the Halal production industry to ensure it produces high quality products of Halal integrity;
• They can benefit from the advice and expertise of HAB and the Halal Authority Inspectors (HAI) to ensure products are Halal;
• The HAB logo can be used on product packaging and labels;
• The company’s details will be added to our database of Certified suppliers, which can be accessed by consumers around the world.

For customers:

There is peace of mind that the products they are purchasing are Halal without having to review the ingredients to decide whether they are suitable. HAB’s Worldwide Standard gives reassurance to Muslim consumers, wherever they are in the world.

On October 29, 2003 the European Commission adopted a proposal for a new EU regulatory framework for chemicals called REACH (Registration, Evaluation and Authorisation of CHemicals). REACH is considered as the world's strictest chemicals law. It is one of the largest-ever EU laws put together by the EU and it will shift responsibilities of collecting chemical security information from regulators to enterprises. This new regulation obliges the producers to register about 30,000 chemical substances placed (produced or imported) on the European single market. Many of the chemicals are substances used in everyday products such as cosmetics, toys and building materials, etc. Eventually, chemicals covered by this new regulation will not be allowed to enter the European market without the compliance to REACH regulations.

Evaluation Process

The evaluation process has three purposes:

• The first purpose is for authorities to evaluate the testing proposals made by industry to ensure the safety of their products and thereby ensuring that animal testing is kept to a minimum.

• The second purpose is to check compliance with the requirements of the regulation.

• The third purpose is to examine any suspicion of risks to human health and the environment arising from substances.

• Evaluation provides a means for the authorities to require registrants, and in very limited cases downstream users, to provide further information.

There are two types of evaluation: dossier evaluation and substance evaluation:

Dossier evaluation is conducted by authorities to examine proposals for testing to ensure that unnecessary animal tests and costs are avoided, and to check the compliance of registration dossier with the registration requirements.

Substance evaluation is performed by authorities when there is a reason to suspect that a substance presents a risk to human health or the environment (e.g. because of its structural similarity to another substance). Therefore, all registration dossiers submitted for a substance are examined together and any other available information is taken into account.

AUTHORISATION

The REACH proposal sets up a system under which the use of substances with properties of very high concern and their placing on the market can be made subject to an authorisation requirement.

This authorisation requirement ensures that risks from the use of such substances are either adequately controlled or justified by socio- economic grounds, having taken into account the available information on alternative substances or processes.

The substances selected for the authorisation system have hazardous properties of such very high concern that the Community needs to decide about the adequacy of the control of risks arising from their uses or about the socio-economic benefits of the uses of such substances that justify risks arising from their use:

Category 1 and 2 CMR substances have effects on humans which are generally so serious and cannot normally be reversed, and PBT and vPvB substances accumulate in living organisms, which cannot normally be reversed, either. To provide a security net, other substances with serious and irreversible effects of an equivalent level of concern as the CMR, PBT and vPvB substances, can be identified on a case-by-case basis. This could
for example be endocrine disrupters which are not already covered by the CMR criteria.

The authorisation provisions require those using or making available substances with properties of very high concern which are included into the system to apply for an authorisation for each use, regardless of the quantity of the substance used, within deadlines set by the Commission. The burden of proof is placed on the applicant to demonstrate that the risk from the use is adequately controlled or that the socio- economic benefits outweigh the risks. In the latter case, applicants need to submit a substitution plan along with a socio-economic analysis.

The Agency, via its Committees for Risk Assessment and Socio-economic Analysis provides opinions on the applications, which the Commission will use for its decisions on applications.

In particular the Authorisation process ensures that:

• The burden of proof to demonstrate that the risk from the use is adequately controlled or that the socio-economic benefits outweigh the risks is placed on the applicants for authorisation.

• The Commission and the MS authorities can monitor the progress;

• The Commission, the MS authorities and industry can focus their resources by starting with those substances that are considered to pose
the greatest current risk and to deliver the 'Highest Expected Regulatory Outcome'(Hero).

RESTRICTIONS

The restrictions procedure is a safety net for substances posing an unacceptable risk to human health or the environment arising from its manufacture, use or placing on the market, which need to be addressed on a Community wide basis.

The basis of the demonstration of the unacceptable risk to human health or the environment on a Community wide basis, will be a risk assessment. This will be different from the CSR of the individual dossiers as they usually won’t deal with regional ‘exposure’, aggregate volumes, and multiple exposures.

A restriction of a substance is any condition for, or prohibition of, its manufacture, use or placing on the market. Restrictions enable risk management measures beyond those already implemented by manufacturers, importers and downstream users, to be introduced across the Community where they are shown to be necessary. Restrictions can also impose a harmonised level of risk management measures. Restrictions apply to all manufacturers, importers, downstream users and distributors of a substance if the manufacture, use or placing on the market (activity) of this substance is included in Annex XVII.

Annex XVII contains restrictions on the manufacture, placing on the market and use of certain dangerous substances, preparations and articles; a consolidation of the restrictions contained in Directive 76/769/EC.

Activities with the substances not included in Annex XVII are allowed, provided there is no restriction in other, sector specific Community legislation, and the substance is not subject to authorisation (Annex XIV).

All substances on their own, in preparations or in articles may be subject to restrictions, regardless of any duty to register the substance. Restrictions apply to activities regardless of the quantity, unless the annex specifies thresholds. However, use of a restricted substance in scientific research and development, as well as product and process oriented research and development activities in quantities below 1 tonne per year, is exempted.

The restrictions also do not apply to substances that are waste being treated in a waste treatment installation within the conditions of a permit.


We provide consultancy service for GMP WHO certification to our clients. GMP (Good Manufacturing Practices) is a standard defined by WHO (World Health Organization). GMP WHO certification ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization.

W.H.O. defines Good Manufacturing Practices (GMP) as "that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization". GMP covers all aspects of the manufacturing process: defined manufacturing process; validated critical manufacturing steps; suitable premises, storage, transport; qualified and trained production and quality control personnel; adequate laboratory facilities; approved written procedures and instructions; records to show all steps of defined procedures taken; full traceability of a product through batch processing records and distribution records; and systems for recall and investigation of complaints.

The guiding principle of GMP is that quality is built into a product, and not just tested into a finished product. Therefore, the assurance is that the product not only meets the final specifications, but that it has been made by the same procedures under the same conditions each and every time it is made. There are many ways this is controlled - controlling the quality of the facility and its systems, controlling the quality of the starting materials, controlling the quality of production at all stages, controlling the quality of the testing of the product, controlling the identity of materials by adequate labeling and segregation, controlling the quality of materials and product by adequate storage, etc. All of these controls must follow prescribed, formal, approved procedures, written as protocols, SOPs, or Master Formulae, describing all the tasks carried out in an entire manufacturing and control process.

GMP covers all aspects of the manufacturing process including :

  • • Defined manufacturing process
  • • Validated critical manufacturing steps
  • • Suitable premises, storage, transport, qualified and trained production and quality control personnel
  • • Adequate laboratory facilities
  • • Approved written procedures and instructions
  • • Records to show all steps of defined procedures have been taken
  • • Full traceability of a product through batch records and distribution records
  • • Systems for recall and investigation of complaints

The UL Mark is a registered certification mark of Underwriters Laboratories Inc. (UL), an independent, not-for-profit, product safety testing and certification organization. The UL Mark may only be used on or in connection with products certified by UL and under the terms of written agreement with UL.

The UL Mark on a product means that UL has tested and evaluated representative samples of that product and determined that it meets UL's requirements. The requirements are primarily based on UL's own published Standards for Safety.

The UL Mark is one of the most recognized, accepted and trusted symbols in the world. Safety-conscious and concerned consumers look for this on products because it delivers the credibility of an independent, technically expert organization which has determined whether foreseeable risks associated with the product's use have been eliminated or minimized. Even after the product is offered in the marketplace, it must continue to meet safety requirements in order to continue bearing the UL Mark, or the mark will be removed by UL.


ISO 50001 specifies requirements for an Energy Management System to enable organization to develop and implement a policy, identify significant areas of energy consumption and target energy reductions. It resents the best practices in energy management building upon existing national standards and initiatives.

Benefits:

  • • A structured approach to identifying, measuring and managing organization’s energy
  • • consumption and create a path to Reduce energy costs.
  • • Reduce Organization’s GHG emissions.
  • • Improve organizatiom‘s image with customers, partners, and the public
  • • Comply with statutory and regulatory requirements.
  • • Increase awareness for the energy management policy and embed energy efficient thinking in
  • • your organization.